NTI drug but with high CV [Power / Sample Size]

posted by Mikalai  – Belarus, 2019-12-14 16:39 (1588 d 11:09 ago) – Posting: # 20975
Views: 3,189

Dear all.
What would be a sample size for a BE study when the CV of the drug is 30% but bioequivalence should be in range 90_110%? Our assumption is around 400 subject if the design is standard, and 200 if the design is replicative
Best regards.

Complete thread:

UA Flag
Activity
 Admin contact
22,988 posts in 4,825 threads, 1,653 registered users;
73 visitors (0 registered, 73 guests [including 5 identified bots]).
Forum time: 04:49 CEST (Europe/Vienna)

The whole purpose of education is
to turn mirrors into windows.    Sydney J. Harris

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5